Department of Neurosurgery, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, The Netherlands.
J Neurosurg. 2011 Dec;115(6):1221-30. doi: 10.3171/2011.6.JNS101491. Epub 2011 Jul 22.
The purpose of this study was to assess flow, patency, and endothelialization of bypasses created with the sutureless Excimer Laser Assisted Non-occlusive Anastomosis (SELANA) technique in a pig model.
In 38 pigs, a bypass was made on the left common carotid artery (CCA), using the right CCA as a graft, with 2 SELANAs. Bypass flow was measured using single-vessel flowmetry. The pigs were randomly assigned to 1 of 12 survival groups (1, 2, 3, 4, 5, 6, 7, and 10 days; 2 and 3 weeks; and 3 and 6 months). One extra animal underwent the procedure and then was killed after 1 hour of bypass patency to serve as a control. Angiography was performed just before the animals were killed, to assess bypass patency. Scanning electron microscopy and histological studies were used to evaluate the anastomoses after planned death.
The mean SELANA bypass flow was not significantly different from the mean flow in the earlier ELANA (Excimer Laser Assisted Non-occlusive Anastomosis) pig study at opening and follow-up. Overall SELANA bypass patency (87%) was not significantly different from the ELANA patency of 86% in the earlier study. Complete SELANA endothelialization was observed after 2-3 weeks, compared with 2 weeks in the earlier ELANA study.
The SELANA technique is not inferior to the current ELANA technique regarding flow, patency, and endothelialization. A pilot study in patients is a logical next step.
本研究旨在评估在猪模型中使用无缝线准分子激光辅助非闭塞吻合术(SELANA)技术制作旁路的血流、通畅性和内皮化情况。
在 38 头猪中,使用右侧颈总动脉(CCA)作为移植物,在左侧颈总动脉上制作旁路,使用 2 个 SELANAs。使用单血管流量测定法测量旁路流量。将猪随机分配到 12 个存活组(1、2、3、4、5、6、7 和 10 天;2 和 3 周;以及 3 和 6 个月)之一。另外一只动物进行了手术,然后在旁路通畅 1 小时后被处死作为对照。在动物被处死前进行血管造影,以评估旁路通畅性。扫描电子显微镜和组织学研究用于评估计划死亡后的吻合口。
平均 SELANA 旁路流量在开放和随访时与早期 ELANA(准分子激光辅助非闭塞吻合术)猪研究中的平均流量没有显著差异。总体而言,SELANA 旁路通畅率(87%)与早期 ELANA 研究中的通畅率(86%)没有显著差异。与早期 ELANA 研究中的 2 周相比,完全的 SELANA 内皮化在 2-3 周后观察到。
SELANA 技术在血流、通畅性和内皮化方面并不逊于当前的 ELANA 技术。对患者进行初步研究是合乎逻辑的下一步。